(Q39939179)

15 September 2017

title

Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-beta1-mediated renal fibrosis and dysfunction (English)

1 reference

15 September 2017

1 reference

Lin Tian

1

1 reference

15 September 2017

Cai Li

2

1 reference

15 September 2017

Jiping Qi

3

1 reference

15 September 2017

Peng Fu

4

1 reference

15 September 2017

Xiaoyan Yu

5

1 reference

15 September 2017

Xiaokun Li

6

1 reference

15 September 2017

Lu Cai

7

1 reference

15 September 2017

publication date

16 September 2008

1 reference

American Journal of Physiology - Endocrinology and Metabolism

15 September 2017

published in

1 reference

15 September 2017

volume

295

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

E1234-42

1 reference

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

State-dependent calcium mobilization by urotensin-II in cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

21 January 2018

Diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Unraveling the active conformation of urotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

The involvement of transforming growth factor-beta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Hypertension Accelerates Diabetic Nephropathy in Wistar Fatty Rats, a Model of Type 2 Diabetes Mellitus, via Mitogen-Activated Protein Kinase Cascades and Transforming Growth Factor-.BETA.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Ligands and signaling of the G-protein-coupled receptor GPR14, expressed in human kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Urotensin II and renal function in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Angiotensin II stimulation of teleost adrenocorticotropic hormone release: interactions with urotensin I and corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90672.2008

10.1152/AJPENDO.90672.2008

21 January 2018

Identifiers

DOI

1 reference

release_xu2jcngpevd3nar7lh67hpsqai

15 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xu2jcngpevd3nar7lh67hpsqai

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference